Can I read Hydroxycarbamide/imatinib: Various toxicities: case report on EtoBox?

Hydroxycarbamide/imatinib: Various toxicities: case report is a Medicine article available to read on EtoBox.

What is Hydroxycarbamide/imatinib: Various toxicities: case report about?

A 64-year-old man (A.C.B) developed gastric adenocarcinoma, mild asthenia and tingling sensation and experienced changes in eating habits during treatment with imatinib and following treatment with hydroxycarbamide for chronic myeloid leukaemia [routes and duration of treatments to reactions onset not stated; not all dosages and outcomes stated]. The man was diagnosed with chronic myeloid leukaemia in November 2008. Afterward, he started receiving treatment with hydroxycarbamide [hydroxyurea] followed by imatinib 400 mg/day. However, he developed mild asthenia and tingling sensation and experienced changes in eating habits secondary to hydroxycarbamide and imatinib. In early 2022, he experienced episodes of major weight loss, nausea, vomiting and epigastric pain. His upper endoscopy which was performed in March 2022 showed an ulcerated lesion of about 2-3cm. His diagnosis of gastric adenocarcinoma secondary to hydroxycarbamide and imatinib was confirmed via immunohistochemistry. Then, the man was treated with oxaliplatin and capecitabine and his therapy with imatinib continued with good response. He also received blood transfusions for digestive tract bleeding.

Who reads Hydroxycarbamide/imatinib: Various toxicities: case report?

Publisher

Springer Science and Business Media LLC

Published

2023

Language

EN

Field

Medicine (Health Sciences)